NAYA Biosciences (NAYA) Competitors $2.18 +0.01 (+0.46%) As of 05/20/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock NAYA vs. CHEK, BLAC, AMIX, QNRX, NUWE, GCTK, HSCS, VERO, TTOO, and TIVCShould you be buying NAYA Biosciences stock or one of its competitors? The main competitors of NAYA Biosciences include Check-Cap (CHEK), Bellevue Life Sciences Acquisition (BLAC), Autonomix Medical (AMIX), Quoin Pharmaceuticals (QNRX), Nuwellis (NUWE), GlucoTrack (GCTK), Heart Test Laboratories (HSCS), Venus Concept (VERO), T2 Biosystems (TTOO), and Tivic Health Systems (TIVC). These companies are all part of the "medical equipment" industry. NAYA Biosciences vs. Check-Cap Bellevue Life Sciences Acquisition Autonomix Medical Quoin Pharmaceuticals Nuwellis GlucoTrack Heart Test Laboratories Venus Concept T2 Biosystems Tivic Health Systems Check-Cap (NASDAQ:CHEK) and NAYA Biosciences (NASDAQ:NAYA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends. Which has more risk & volatility, CHEK or NAYA? Check-Cap has a beta of 0.21, indicating that its stock price is 79% less volatile than the S&P 500. Comparatively, NAYA Biosciences has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Does the MarketBeat Community believe in CHEK or NAYA? Check-Cap received 369 more outperform votes than NAYA Biosciences when rated by MarketBeat users. However, 100.00% of users gave NAYA Biosciences an outperform vote while only 60.76% of users gave Check-Cap an outperform vote. CompanyUnderperformOutperformCheck-CapOutperform Votes37060.76% Underperform Votes23939.24% NAYA BiosciencesOutperform Votes1100.00% Underperform VotesNo Votes Which has preferable earnings and valuation, CHEK or NAYA? NAYA Biosciences has higher revenue and earnings than Check-Cap. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$17.57M-$3.00-0.29NAYA Biosciences$6.23M0.23-$8.03MN/AN/A Do insiders & institutionals believe in CHEK or NAYA? 1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 12.0% of NAYA Biosciences shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 1.8% of NAYA Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is CHEK or NAYA more profitable? Check-Cap has a net margin of 0.00% compared to NAYA Biosciences' net margin of -119.91%. Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A NAYA Biosciences -119.91%N/A -41.72% Do analysts rate CHEK or NAYA? NAYA Biosciences has a consensus target price of $24.00, suggesting a potential upside of 1,000.92%. Given NAYA Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe NAYA Biosciences is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NAYA Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer CHEK or NAYA? In the previous week, Check-Cap had 1 more articles in the media than NAYA Biosciences. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for NAYA Biosciences. Check-Cap's average media sentiment score of 0.00 equaled NAYA Biosciences'average media sentiment score. Company Overall Sentiment Check-Cap Neutral NAYA Biosciences Neutral SummaryNAYA Biosciences beats Check-Cap on 9 of the 13 factors compared between the two stocks. Get NAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NAYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAYA vs. The Competition Export to ExcelMetricNAYA BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45M$4.50B$5.38B$8.39BDividend YieldN/A43.63%5.21%4.10%P/E RatioN/A29.4326.8019.71Price / Sales0.2367.72389.55117.28Price / CashN/A51.0838.2534.62Price / Book-1.066.236.804.50Net Income-$8.03M$68.16M$3.23B$248.18M7 Day Performance7.92%-0.19%1.53%0.23%1 Month Performance21.11%19.19%10.05%12.39%1 Year PerformanceN/A21.47%16.75%7.07% NAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAYANAYA BiosciencesN/A$2.18+0.5%$24.00+1,000.9%N/A$1.45M$6.23M0.0010High Trading VolumeCHEKCheck-Cap0.3988 of 5 stars$0.91-6.5%N/A-60.2%$5.31MN/A-0.3080News CoverageAnalyst ForecastGap DownBLACBellevue Life Sciences AcquisitionN/A$1.21-3.2%N/A-89.5%$4.89MN/A0.00N/AGap UpHigh Trading VolumeAMIXAutonomix Medical2.2803 of 5 stars$1.90+9.2%$16.50+768.4%-96.0%$4.68MN/A-0.151High Trading VolumeQNRXQuoin Pharmaceuticals0.347 of 5 stars$7.70+0.7%N/A-67.7%$4.53MN/A-1.904Gap DownNUWENuwellis2.5045 of 5 stars$0.96-0.5%$17.00+1,670.8%-90.1%$4.20M$8.74M-0.0170GCTKGlucoTrack0.9899 of 5 stars$0.15+0.1%N/A-99.7%$3.83MN/A0.005Positive NewsGap UpHigh Trading VolumeHSCSHeart Test Laboratories2.4015 of 5 stars$3.36+0.6%$13.00+286.9%-30.7%$3.63M$14,700.00-0.4210Gap UpVEROVenus Concept0.8629 of 5 stars$2.22-8.6%N/A-66.7%$3.16M$64.83M-0.28410Positive NewsEarnings ReportGap UpTTOOT2 BiosystemsN/A$0.15-10.6%$5.00+3,231.1%-97.1%$3.16M$7.68M0.00180Analyst ForecastGap DownTIVCTivic Health Systems0.0887 of 5 stars$4.32flatN/A-45.1%$2.65M$780,000.000.0010Earnings ReportGap Up Related Companies and Tools Related Companies CHEK Alternatives BLAC Alternatives AMIX Alternatives QNRX Alternatives NUWE Alternatives GCTK Alternatives HSCS Alternatives VERO Alternatives TTOO Alternatives TIVC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAYA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAYA Stock Free NAYA Stock Alerts